185 related articles for article (PubMed ID: 21561394)
21. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.
Hoy SM
CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
Ben-Menachem E; Biton V; Jatuzis D; Abou-Khalil B; Doty P; Rudd GD
Epilepsia; 2007 Jul; 48(7):1308-17. PubMed ID: 17635557
[TBL] [Abstract][Full Text] [Related]
24. Retigabine as add-on treatment of refractory epilepsy--a cost-utility study in a Swedish setting.
Kristian B; Wachtmeister K; Stefan F; Forsgren L
Acta Neurol Scand; 2013 Jun; 127(6):419-26. PubMed ID: 23368976
[TBL] [Abstract][Full Text] [Related]
25. Minimizing pharmacodynamic interactions of high doses of lacosamide.
Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL
Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
Gavatha M; Ioannou I; Papavasiliou AS
Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334
[TBL] [Abstract][Full Text] [Related]
27. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
Wisniewski CS
Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
[TBL] [Abstract][Full Text] [Related]
28. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
29. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
30. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
Beydoun A; D'Souza J; Hebert D; Doty P
Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
[TBL] [Abstract][Full Text] [Related]
31. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
Ben-Menachem E
Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
[TBL] [Abstract][Full Text] [Related]
32. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
33. Lacosamide and epilepsy.
Harris JA; Murphy JA
CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
[TBL] [Abstract][Full Text] [Related]
34. Lacosamide: new adjunctive treatment option for partial-onset seizures.
Chung SS
Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre.
Kamel JT; DeGruyter MA; D'Souza WJ; Cook MJ
Acta Neurol Scand; 2013 Mar; 127(3):149-53. PubMed ID: 22845761
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
38. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
39. Lacosamide: new drug. Refractory partial epilepsy: optimise existing combinations.
Prescrire Int; 2009 Oct; 18(103):196. PubMed ID: 19882781
[No Abstract] [Full Text] [Related]
40. Experience with lacosamide in a series of children with drug-resistant focal epilepsy.
Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV
Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
